Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound amino acid capsule

A technology of capsules and capsule shells, which can be used in capsule delivery, pharmaceutical formulations, active ingredients of hydroxyl compounds, etc., can solve problems such as huge medical burden and high production costs.

Active Publication Date: 2016-06-15
李兴惠
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Compared with the conventional powder / granule capsule process, this preparation process has significantly higher production costs, which will bring a huge medical burden to patients.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound amino acid capsule
  • Compound amino acid capsule
  • Compound amino acid capsule

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] Embodiment 1: preparation capsule

[0092] formula:

[0093] L-leucine

18.3mg

L-isoleucine

5.9mg

L-Lysine Hydrochloride

25mg

L-phenylalanine

5mg

L-threonine

4.2mg

L-valine

6.7mg

L-tryptophan

5mg

DL-methionine

18.4mg

Vitamin A

2000IU

Vitamin D2

200IU

Vitamin B1

5mg

Vitamin B2

3mg

Nicotinamide

2mg

Vitamin B6

2.5mg

folic acid

0.2mg

thbrthdrexvbdr

5mg

Vitamin B12

1ug

Vitamin C

20mg

Vitamin E

1mg

5-Hydroxyanthranilic acid hydrochloride

0.2mg

starch

170mg

Magnesium stearate*

2%

[0094] Note: *Magnesium stearate is fed as a percentage of the total weight of the capsule filling, the same below.

[0095] Method 1:

[0096] (i) each solid material is crushed into powder that can pass through a 65 mesh sieve;

[0097] (ii) mix each material evenly to form final...

Embodiment 2

[0105] Embodiment 2: preparation capsule

[0106] formula:

[0107]

[0108]

[0109] Preparation method:

[0110] (i) each solid material is crushed into powder that can pass through a 65 mesh sieve;

[0111] (ii) mix each material evenly to form a final mixed powder (its particle size is: more than 90% of the particles can pass through a 65-mesh sieve);

[0112] (iii) Fill the final mixed powder into the hard capsule shell (F20020035), put the capsule body and capsule cap together, and seal it to get ready.

Embodiment 3

[0113] Embodiment 3: preparation capsule

[0114] formula:

[0115] L-leucine

14.5mg

L-isoleucine

4.5mg

L-Lysine Hydrochloride

30mg

L-phenylalanine

6mg

L-threonine

3.3mg

L-valine

5.3mg

L-tryptophan

6mg

DL-methionine

22mg

Vitamin A

1600IU

Vitamin D2

160IU

Vitamin B1

6mg

Vitamin B2

2.4mg

Nicotinamide

1.6mg

Vitamin B6

3mg

folic acid

0.24mg

thbrthdrexvbdr

4mg

Vitamin B12

0.8ug

Vitamin C

24mg

Vitamin E

1.2mg

5-Hydroxyanthranilic acid hydrochloride

0.16mg

starch

100mg

Magnesium stearate

5%

[0116] Preparation method:

[0117] (i) each solid material is crushed into powder that can pass through a 65 mesh sieve;

[0118] (ii) mix each material evenly to form a final mixed powder (its particle size is: more than 95% of the particles can pass through a 65-mesh sieve);...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a compound amino acid capsule. The compound amino acid capsule comprises a capsule shell and powdery or granular filler wrapped in the capsule shell, wherein the capsule shell is a hollow gelatin capsule prepared from gelatin as a main component; the filler comprises active substances and pharmaceutic adjuvants. The compound amino acid capsule adopts a scientific and reasonable ratio, has good product stability, is free of toxic and side effects, has high safety and good biological effect, and can be applied to preparation of drugs for treating chronic liver and kidney diseases and food for relieving and eliminating physical fatigue caused by exercise training. The capsule has the characteristics superior to those in the prior art.

Description

technical field [0001] The invention relates to a capsule medicament and a preparation method thereof, specifically, a capsule containing 8 kinds of amino acids and 11 kinds of vitamin pellets, also known as a compound amino acid capsule, and a preparation method of the capsule. Background technique [0002] Protein is the material basis of human life activities. Various physiological functions of the human body, especially immune function, cell damage repair function and growth and development function, are closely related to the normality of its metabolism. Under normal circumstances, the human body obtains various amino acids through the protein in food to ensure the normal protein metabolism of the body. Among the 20 kinds of amino acids needed for human protein synthesis, 8 kinds of amino acids are essential amino acids for the human body. These 8 kinds of amino acids cannot be synthesized by the body itself and must rely on external supply. They are isoleucine, leucin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/198A61K31/405A61K31/07A61K31/592A61K31/51A61K31/525A61K31/455A61K31/4415A61K31/519A61K31/197A61K31/714A61K31/375A61K31/355A61K31/606A61K9/48A61P1/16A61P13/12A61P3/02
CPCA61K9/4866A61K31/07A61K31/197A61K31/198A61K31/355A61K31/375A61K31/405A61K31/4415A61K31/455A61K31/51A61K31/519A61K31/525A61K31/592A61K31/606A61K31/714A61K2300/00
Inventor 李兴惠
Owner 李兴惠
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products